BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 18806625)

  • 1. Protective effect of candesartan in experimental ischemic stroke in the rat mediated by AT2 and AT4 receptors.
    Faure S; Bureau A; Oudart N; Javellaud J; Fournier A; Achard JM
    J Hypertens; 2008 Oct; 26(10):2008-15. PubMed ID: 18806625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective mechanisms of the angiotensin II type 1 receptor blocker candesartan against cerebral ischemia: in-vivo and in-vitro studies.
    Liu H; Kitazato KT; Uno M; Yagi K; Kanematsu Y; Tamura T; Tada Y; Kinouchi T; Nagahiro S
    J Hypertens; 2008 Jul; 26(7):1435-45. PubMed ID: 18551021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebroprotective effect of angiotensin IV in experimental ischemic stroke in the rat mediated by AT(4) receptors.
    Faure S; Chapot R; Tallet D; Javellaud J; Achard JM; Oudart N
    J Physiol Pharmacol; 2006 Sep; 57(3):329-42. PubMed ID: 17033088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotection against retinal ischemia-reperfusion injury by blocking the angiotensin II type 1 receptor.
    Fukuda K; Hirooka K; Mizote M; Nakamura T; Itano T; Shiraga F
    Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3629-38. PubMed ID: 20164447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-AT(1)-receptor-mediated protective effect of angiotensin against acute ischaemic stroke in the gerbil.
    Dalmay F; Mazouz H; Allard J; Pesteil F; Achard JM; Fournier A
    J Renin Angiotensin Aldosterone Syst; 2001 Jun; 2(2):103-6. PubMed ID: 11881107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of angiotensin II type 1 receptor blocker, candesartan, and beta 1 adrenoceptor blocker, atenolol, on brain damage in ischemic stroke.
    Saad MA; Abbas AM; Boshra V; Elkhateeb M; El Aal IA
    Acta Physiol Hung; 2010 Jun; 97(2):159-71. PubMed ID: 20511125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasoconstrictive effect of angiotensin IV in isolated rat basilar artery independent of AT1 and AT2 receptors.
    Faure S; Javellaud J; Achard JM; Oudart N
    J Vasc Res; 2006; 43(1):19-26. PubMed ID: 16254439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effects of postischemic treatment with hypotensive doses of an angiotensin II receptor blocker on transient focal cerebral ischemia.
    Fu H; Hosomi N; Pelisch N; Nakano D; Liu G; Ueno M; Miki T; Masugata H; Sueda Y; Itano T; Matsumoto M; Nishiyama A; Kohno M
    J Hypertens; 2011 Nov; 29(11):2210-9. PubMed ID: 21934531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow-dependent dilation mediated by endogenous kinins requires angiotensin AT2 receptors.
    Bergaya S; Hilgers RH; Meneton P; Dong Y; Bloch-Faure M; Inagami T; Alhenc-Gelas F; Lévy BI; Boulanger CM
    Circ Res; 2004 Jun; 94(12):1623-9. PubMed ID: 15131008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II type 2 receptor vasoactivity in internal mammary arteries of patients with coronary artery disease.
    van de Wal RM; van der Harst P; Wagenaar LJ; Wassmann S; Morshuis WJ; Nickenig G; Buikema H; Plokker HW; van Veldhuisen DJ; van Gilst WH; Voors AA
    J Cardiovasc Pharmacol; 2007 Oct; 50(4):372-9. PubMed ID: 18049304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candesartan but not ramipril pretreatment improves outcome after stroke and stimulates neurotrophin BNDF/TrkB system in rats.
    Krikov M; Thone-Reineke C; Müller S; Villringer A; Unger T
    J Hypertens; 2008 Mar; 26(3):544-52. PubMed ID: 18300867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of cerebral infarct size by the AT1-receptor blocker candesartan, the HMG-CoA reductase inhibitor rosuvastatin and their combination. An experimental study in rats.
    Engelhorn T; Doerfler A; Heusch G; Schulz R
    Neurosci Lett; 2006 Oct; 406(1-2):92-6. PubMed ID: 16901636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin AT2 receptor protects against cerebral ischemia-induced neuronal injury.
    Li J; Culman J; Hörtnagl H; Zhao Y; Gerova N; Timm M; Blume A; Zimmermann M; Seidel K; Dirnagl U; Unger T
    FASEB J; 2005 Apr; 19(6):617-9. PubMed ID: 15665034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin AT2 receptor contributes to cardiovascular remodelling of aged rats during chronic AT1 receptor blockade.
    Jones ES; Black MJ; Widdop RE
    J Mol Cell Cardiol; 2004 Nov; 37(5):1023-30. PubMed ID: 15522279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal angiotensin type 2 receptors mediate natriuresis via angiotensin III in the angiotensin II type 1 receptor-blocked rat.
    Padia SH; Howell NL; Siragy HM; Carey RM
    Hypertension; 2006 Mar; 47(3):537-44. PubMed ID: 16380540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood pressure lowering after experimental cerebral ischemia provides neurovascular protection.
    Elewa HF; Kozak A; Johnson MH; Ergul A; Fagan SC
    J Hypertens; 2007 Apr; 25(4):855-9. PubMed ID: 17351379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the angiotensin AT1 receptor blocker candesartan on myocardial ischemic/reperfusion injury.
    Shimizu M; Sjöquist PO; Wang QD; Rydén L
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S137-42. PubMed ID: 9892154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between early and delayed systemic treatment with candesartan of rats after ischaemic stroke.
    Brdon J; Kaiser S; Hagemann F; Zhao Y; Culman J; Gohlke P
    J Hypertens; 2007 Jan; 25(1):187-96. PubMed ID: 17143191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AT2 receptors contribute to acute blood pressure-lowering and vasodilator effects of AT1 receptor antagonism in conscious normotensive but not hypertensive rats.
    Duke LM; Evans RG; Widdop RE
    Am J Physiol Heart Circ Physiol; 2005 May; 288(5):H2289-97. PubMed ID: 15615839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic angiotensin II receptor blockade induces cardioprotection during ischemia by increased PKC-epsilon expression in the mouse heart.
    Lange SA; Wolf B; Schober K; Wunderlich C; Marquetant R; Weinbrenner C; Strasser RH
    J Cardiovasc Pharmacol; 2007 Jan; 49(1):46-55. PubMed ID: 17261963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.